Pembrolizumab-associated choroidal inflammation on a background of treated choroidal melanoma
BMJ Case Reports · 2026-06 · 19 (6) · e265373
DOI: 10.1136/bcr-2025-265373 ↗Kurz gefasst
Fallbericht in der Zeitschrift BMJ Case Reports, online erschienen am 19.06.2026. Verfasst von Patrick Murtagh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK murtagp@tcd.ie. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Melanoma, Choroid Neoplasms, Antineoplastic Agents, Immunological. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
We report a rare case of isolated choroidal inflammation in a patient with a history of treated choroidal melanoma who subsequently developed cutaneous melanoma and underwent adjuvant treatment with pembrolizumab. The patient presented with a new choroidal lesion adjacent to the treated choroidal melanoma. Differential diagnosis included recurrence of choroidal melanoma, metastases from the cutaneous melanoma or pembrolizumab-associated choroidal inflammation. Ultrasound findings suggested an inflammatory aetiology and the patient was treated with an intravitreal dexamethasone implant. One month later, the lesion had regressed and visual acuity improved. Pembrolizumab, an immune checkpoint inhibitor, can cause ocular immune-related adverse effects, including choroidal inflammation. This case underscores the importance of distinguishing between inflammatory and metastatic lesions, particularly in patients with a history of ocular malignancy. Early recognition and appropriate treatment with steroids can prevent irreversible vision loss and multimodal imaging is crucial in such cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK murtagp@tcd.ie.
- Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
Zitieren
APA
Murtagh, P., Gatchalian, L., Hussain, R., & Heimann, H. (2026). Pembrolizumab-associated choroidal inflammation on a background of treated choroidal melanoma. BMJ Case Reports, 19(6), e265373. https://doi.org/10.1136/bcr-2025-265373
Vancouver
Murtagh P, Gatchalian L, Hussain R, Heimann H. Pembrolizumab-associated choroidal inflammation on a background of treated choroidal melanoma. BMJ Case Reports. 2026;19(6):e265373. doi:10.1136/bcr-2025-265373
BibTeX
@article{Murtagh2026,
author = {Murtagh, Patrick and Gatchalian, Leandro and Hussain, Rumana and Heimann, Heinrich},
title = {Pembrolizumab-associated choroidal inflammation on a background of treated choroidal melanoma},
journal = {BMJ Case Reports},
year = {2026},
volume = {19},
number = {6},
pages = {e265373},
doi = {10.1136/bcr-2025-265373}
}
EUVIMED